Cargando…

Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial

OBJECTIVE: SSRIs are considered the first line in the medical treatment of depression and anxiety disorders. One of their most common side effects, sexual dysfunction, has led many patients to discontinuing their medication and treatment course. Alpinia galanga, a plant from the ginger family, has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbarzadeh, Farzad, Eslamzadeh, Mahboubeh, Behravan, Ghazal, Ebrahimi, Alireza, Emami, Seyed Ahmad, Gilan, Atefe, Hoseinian, Najme Sadat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151528/
https://www.ncbi.nlm.nih.gov/pubmed/37143784
http://dx.doi.org/10.3389/fpsyt.2023.1105828
_version_ 1785035555135815680
author Akbarzadeh, Farzad
Eslamzadeh, Mahboubeh
Behravan, Ghazal
Ebrahimi, Alireza
Emami, Seyed Ahmad
Gilan, Atefe
Hoseinian, Najme Sadat
author_facet Akbarzadeh, Farzad
Eslamzadeh, Mahboubeh
Behravan, Ghazal
Ebrahimi, Alireza
Emami, Seyed Ahmad
Gilan, Atefe
Hoseinian, Najme Sadat
author_sort Akbarzadeh, Farzad
collection PubMed
description OBJECTIVE: SSRIs are considered the first line in the medical treatment of depression and anxiety disorders. One of their most common side effects, sexual dysfunction, has led many patients to discontinuing their medication and treatment course. Alpinia galanga, a plant from the ginger family, has been shown to enhance androgenic activity and sexual function. This study aimed to assess whether the addition of Alpinia galanga extract to the treatment regimen of adult males consuming SSRIs can improve SSRI-induced erectile dysfunction. MATERIALS AND METHODS: This triple-blind randomized clinical trial was conducted on 60 adult males who were being treated with SSRIs at the time of the study. The participants were divided into two groups, a group of 30 people receiving 500 mg of Alpinia galanga extract and a group of 30 subjects receiving placebo. The population were re-assessed on week 2 and week 4 of the study using the international index of erectile function (IIEF), the Beck Depression Inventory, and the Beck Anxiety Inventory. In all the tests, a p-value of 0.05 was considered as the cut-off for significance. RESULTS: At the beginning of the study, the IIEF scores of the placebo group and the intervention group were 10.6 ± 3.8 and 11.2 ± 4.8, respectively, which were not significantly different (p-value = 0.577). By week 4 of the study, the IIEF scores of the control group and the Alpinia galanga group had increased to 13.7 ± 4.3 and 17.4 ± 3.7 respectively, which demonstrates a remarkably larger increase in the group receiving Alpinia galanga extract in comparison to the placebo group (p-value < 0.001). CONCLUSION: In this study, the effect of the addition of Alpinia galanga extract to the treatment regimen of male patients using SSRIs on the sexual dysfunction experienced by this group has been promising. Similar results, if proven, can aid both patients and clinicians in making and following better treatment plans with more pleasant outcomes. CLINICAL TRIAL REGISTRATION: [https://clinicaltrials.gov/], identifier [IRCT20101130005280N41].
format Online
Article
Text
id pubmed-10151528
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101515282023-05-03 Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial Akbarzadeh, Farzad Eslamzadeh, Mahboubeh Behravan, Ghazal Ebrahimi, Alireza Emami, Seyed Ahmad Gilan, Atefe Hoseinian, Najme Sadat Front Psychiatry Psychiatry OBJECTIVE: SSRIs are considered the first line in the medical treatment of depression and anxiety disorders. One of their most common side effects, sexual dysfunction, has led many patients to discontinuing their medication and treatment course. Alpinia galanga, a plant from the ginger family, has been shown to enhance androgenic activity and sexual function. This study aimed to assess whether the addition of Alpinia galanga extract to the treatment regimen of adult males consuming SSRIs can improve SSRI-induced erectile dysfunction. MATERIALS AND METHODS: This triple-blind randomized clinical trial was conducted on 60 adult males who were being treated with SSRIs at the time of the study. The participants were divided into two groups, a group of 30 people receiving 500 mg of Alpinia galanga extract and a group of 30 subjects receiving placebo. The population were re-assessed on week 2 and week 4 of the study using the international index of erectile function (IIEF), the Beck Depression Inventory, and the Beck Anxiety Inventory. In all the tests, a p-value of 0.05 was considered as the cut-off for significance. RESULTS: At the beginning of the study, the IIEF scores of the placebo group and the intervention group were 10.6 ± 3.8 and 11.2 ± 4.8, respectively, which were not significantly different (p-value = 0.577). By week 4 of the study, the IIEF scores of the control group and the Alpinia galanga group had increased to 13.7 ± 4.3 and 17.4 ± 3.7 respectively, which demonstrates a remarkably larger increase in the group receiving Alpinia galanga extract in comparison to the placebo group (p-value < 0.001). CONCLUSION: In this study, the effect of the addition of Alpinia galanga extract to the treatment regimen of male patients using SSRIs on the sexual dysfunction experienced by this group has been promising. Similar results, if proven, can aid both patients and clinicians in making and following better treatment plans with more pleasant outcomes. CLINICAL TRIAL REGISTRATION: [https://clinicaltrials.gov/], identifier [IRCT20101130005280N41]. Frontiers Media S.A. 2023-04-18 /pmc/articles/PMC10151528/ /pubmed/37143784 http://dx.doi.org/10.3389/fpsyt.2023.1105828 Text en Copyright © 2023 Akbarzadeh, Eslamzadeh, Behravan, Ebrahimi, Emami, Gilan and Hoseinian. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Akbarzadeh, Farzad
Eslamzadeh, Mahboubeh
Behravan, Ghazal
Ebrahimi, Alireza
Emami, Seyed Ahmad
Gilan, Atefe
Hoseinian, Najme Sadat
Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial
title Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial
title_full Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial
title_fullStr Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial
title_full_unstemmed Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial
title_short Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial
title_sort assessing the effect of alpinia galanga extract on the treatment of ssri-induced erectile dysfunction: a randomized triple-blind clinical trial
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151528/
https://www.ncbi.nlm.nih.gov/pubmed/37143784
http://dx.doi.org/10.3389/fpsyt.2023.1105828
work_keys_str_mv AT akbarzadehfarzad assessingtheeffectofalpiniagalangaextractonthetreatmentofssriinducederectiledysfunctionarandomizedtripleblindclinicaltrial
AT eslamzadehmahboubeh assessingtheeffectofalpiniagalangaextractonthetreatmentofssriinducederectiledysfunctionarandomizedtripleblindclinicaltrial
AT behravanghazal assessingtheeffectofalpiniagalangaextractonthetreatmentofssriinducederectiledysfunctionarandomizedtripleblindclinicaltrial
AT ebrahimialireza assessingtheeffectofalpiniagalangaextractonthetreatmentofssriinducederectiledysfunctionarandomizedtripleblindclinicaltrial
AT emamiseyedahmad assessingtheeffectofalpiniagalangaextractonthetreatmentofssriinducederectiledysfunctionarandomizedtripleblindclinicaltrial
AT gilanatefe assessingtheeffectofalpiniagalangaextractonthetreatmentofssriinducederectiledysfunctionarandomizedtripleblindclinicaltrial
AT hoseiniannajmesadat assessingtheeffectofalpiniagalangaextractonthetreatmentofssriinducederectiledysfunctionarandomizedtripleblindclinicaltrial